What might be most surprising about this week’s recommended stem cell research reads is there’s nothing about COVID-19 in here. There are, however, some really great papers. And we can expect more developments on the cellular medicine for COVID-19 front coming soon. Before I jump into the reads, if you haven’t already check out our […]
Weekly stem cell research reads: BAF, Polycomb, Fertility, More Read More »
The title of a new article in Stem Cells and Development may seem audacious to those unfamiliar with the plight of the northern white rhino and the promise of induced pluripotent stem cells. But “Rewinding Extinction in the Northern White Rhinoceros” may turn out to be accurate for what a genetically diverse stem cell bank
Will Stem Cells Save the Northern White Rhino? Read More »
Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. Stem cell biotechs These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell
24 cell therapy & stem cell stocks I’m following Read More »
There are weeks when it seems like papers on stem cells keep popping up. It can be a challenge to keep up with reading all the papers you want to read. Other times it is cell biology news that keeps breaking. The big news of the past week or so was unfortunately the concerning development
Recommended reads: stem cells on the brain, heart, COVID Read More »
Somehow time has flown by so that I’ve been around for ages in the stem cell universe and some unproven stem cell clinic-type firms, like the well-known Panama stem cell clinic that sells autism “treatments”, are also long-timers. It’s been an odd parallel existence for more than a decade. Today’s post is focused on this
Fact-Checking Panama stem cell institute: cost, safety, efficacy, docs Read More »
At times there’s been seriously bad journalism covering COVID-19 itself including implications of various things being a COVID cure. Of course, media coverage of stem cell research itself sometimes ends up being a train-wreck of hype too. More recently we’ve seen irresponsible journalism also around the specific idea of stem cells for COVID-19, but sometimes
Fact-check: F grade for irresponsible stem cell COVID-19 cure piece Read More »
I confess that I’m old enough to remember when the acronym MSC stood unambiguously for “mesenchymal stem cells”, but should it refer to a broader term like “mesenchymal cells”? The field has moved in that direction. I think that’s the best way to go too and I’ll explain why. The goal of today’s post is
Mesenchymal cells or MSCs: definition, clinical potential, challenges Read More »
A grand jury indicted Missouri state representative and assistant physician Patricia Derges for allegedly selling and injecting patients with fake stem cells. The injection was reportedly just of amniotic fluid, but Derges allegedly claimed it was a stem cell treatment. NBC News was one of several media outlets that broke the story here after the
Lawmaker indicted for selling fake stem cells for COVID & more Read More »
Science must go on and so must stem cell meetings 2021 with all those great conferences out there, but this year it’s going to be different, right? Every year I put up a continually-updated list of stem cell meetings and conferences. I’ve got my 2021 even if most of what’s out there is going to
Hub of Regenerative Medicine & Stem Cell Meetings 2021 Read More »
Induced pluripotent stem cells or iPS cells just might be the most exciting development in the stem cell field over the last 15 years. They have unique potential for clinical impact for regenerative medicine too. This may manifest both through their use to produce differentiated cellular therapies and indirectly via disease modeling as well as
What are induced pluripotent stem cells or IPS cells? Read More »